1.

Record Nr.

UNICAMPANIASUN0101922

Titolo

Dignità della persona : riconoscimento dei diritti nelle società multiculturali / a cura di Angelo Abignente e Francesca Scamardella

Pubbl/distr/stampa

Napoli : Editoriale scientifica, 2013

ISBN

978-88-634-2347-1

Descrizione fisica

XIV, 295 p. ; 22 cm.

Soggetti

Dignità umana - Tutela

Lingua di pubblicazione

Italiano

Formato

Materiale a stampa

Livello bibliografico

Monografia

2.

Record Nr.

UNINA9910970994503321

Titolo

The anthrax vaccine : is it safe? does it work? / / Lois M. Joellenbeck ... [et al.], editors ; Committee to Assess the Safety and Efficacy of the Anthrax Vaccine, Medical Follow-up Agency, Institute of Medicine

Pubbl/distr/stampa

Washington, D.C., : National Academy Press, c2002

ISBN

9786612083914

9780309182744

0309182743

9781282083912

1282083910

9780309557849

0309557844

9780309528894

0309528895

Edizione

[1st ed.]

Descrizione fisica

1 online resource (288 p.)

Disciplina

614.5/61

Soggetti

Anthrax - Vaccination

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia



Note generali

Description based upon print version of record.

Nota di bibliografia

Includes bibliographical references.

Nota di contenuto

""Front Matter""; ""Preface""; ""Acknowledgments""; ""Reviewers""; ""Contents""; ""Figures, Tables, and Boxes""; ""Abbreviations and Acronyms""; ""Executive Summary""; ""1 Introduction""; ""2 Background""; ""3 Anthrax Vaccine Efficacy""; ""4 Safety: Introduction""; ""5 Safety: Case Reports""; ""6 Safety: Epidemiologic Studies""; ""7 Anthrax Vaccine Manufacture""; ""8 Future Needs""; ""Appendix A Statement of Task""; ""Appendix B Biographical Sketches""; ""Appendix C Information-Gathering Meeting Agendas""; ""Appendix D Anthrax Vaccine Adsorbed Package Inserts""

""Appendix E Vaccine Adverse Event Reporting System (VAERS) Form""""Appendix F Anthrax Vaccine Expert Committee (AVEC) Case Assessment Form""; ""Appendix G DMSS Analyses Requested by the IOM Committee to Assess the Safety and Efficacy of the Anthrax Vaccine""; ""An Assessment of the Safety of the Anthrax Vaccine A Letter Report Appendix H""

Sommario/riassunto

The vaccine used to protect humans against the anthrax disease, called Anthrax Vaccine Adsorbed (AVA), was licensed in 1970. It was initially used to protect people who might be exposed to anthrax where they worked, such as veterinarians and textile plant workers who process animal hair. When the U. S. military began to administer the vaccine, then extended a plan for the mandatory vaccination of all U. S. service members, some raised concerns about the safety and efficacy of AVA and the manufacture of the vaccine. In response to these and other concerns, Congress directed the Department of Defense to support an independent examination of AVA.  The Anthrax Vaccine: Is It Safe? Does It Work? reports the study (TM)s conclusion that the vaccine is acceptably safe and effective in protecting humans against anthrax. The book also includes a description of advances needed in main areas: improving the way the vaccine is now used, expanding surveillance efforts to detect side effects from its use, and developing a better vaccine.